ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
| Title: | ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy |
|---|---|
| Authors: | Soumoy, LauraAff1, Aff5, IDs1293502303196y_cor1; Genbauffe, AlineAff1; Mouchart, LenaAff1; Sperone, AlexandraAff1; Trelcat, AnneAff1; Mukeba-Harchies, LéaAff1; Wells, MathildeAff2; Blankert, BertrandAff2; Najem, AhmadAff3; Ghanem, GhanemAff3; Saussez, SvenAff1, Aff4; Journe, FabriceAff1, Aff3, IDs1293502303196y_cor12 |
| Source: | Cancer Cell International. 24(1) |
| Database: | Springer Nature Journals |